Chemotherapy enhances CD8+ T cell-mediated antitumor immunity induced by vaccination with vaccinia virus

Chung Kil Song, Hee Dong Han, Kyung Hee Noh, Tae Heung Kang, Yong Sung Park, Jin Hee Kim, Eun Suk Park, Byung Cheol Shin, Tae Woo Kim

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The use of immunotherapy or chemotherapy alone is generally ineffective against well-established tumors. To overcome this intrinsic resistance against therapy for tumors, we have attempted to combine immunotherapy with chemotherapy. In this study, we tried to induce a rapid antitumor effect via chemoimmunotherapy using a vaccinia viral vaccine as an immunotherapeutic agent with anticancer agents including epigallocatechin-3-gallate (EGCG) and conventional anticancer drugs. Although a combination of vaccinia-mediated vaccination and chemotherapy led to a strong inhibition of tumor growth, monotherapy alone failed to completely cure tumors. In contrast, intravenous injection of cisplatin (CDDP) or cyclophosphamide (CTX) after vaccinia virus vaccination led to complete regression of the established tumors. Interestingly, anticancer drugs appear to augment the antitumor effect of the vaccinia virus-mediated immunotherapy. This effect is mainly associated with the enhanced tumor-specific CD8+ T cell immune response induced by vaccinia virus, which was demonstrated by antibody depletion. However, anticancer drugs alone failed to induce a significant enhancement of the tumor-specific CD8+ T cell immune response. Taken together, these results suggest that combining vaccinia virus-based immunotherapy with anticancer drugs is particularly effective against established tumors by increasing the tumor antigen-specific CD8+ T cell immune response, which is primed by vaccinia virus-mediated vaccination.

Original languageEnglish
Pages (from-to)1558-1563
Number of pages6
JournalMolecular Therapy
Volume15
Issue number8
DOIs
Publication statusPublished - 2007 Aug 1

Fingerprint

Vaccinia virus
Cellular Immunity
Vaccination
T-Lymphocytes
Drug Therapy
Immunotherapy
Neoplasms
Vaccinia
Pharmaceutical Preparations
Viral Vaccines
Neoplasm Antigens
Intravenous Injections
Antineoplastic Agents
Cyclophosphamide
Cisplatin
Antibodies
Growth

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Chemotherapy enhances CD8+ T cell-mediated antitumor immunity induced by vaccination with vaccinia virus. / Song, Chung Kil; Han, Hee Dong; Noh, Kyung Hee; Kang, Tae Heung; Park, Yong Sung; Kim, Jin Hee; Park, Eun Suk; Shin, Byung Cheol; Kim, Tae Woo.

In: Molecular Therapy, Vol. 15, No. 8, 01.08.2007, p. 1558-1563.

Research output: Contribution to journalArticle

Song, CK, Han, HD, Noh, KH, Kang, TH, Park, YS, Kim, JH, Park, ES, Shin, BC & Kim, TW 2007, 'Chemotherapy enhances CD8+ T cell-mediated antitumor immunity induced by vaccination with vaccinia virus', Molecular Therapy, vol. 15, no. 8, pp. 1558-1563. https://doi.org/10.1038/sj.mt.6300221
Song, Chung Kil ; Han, Hee Dong ; Noh, Kyung Hee ; Kang, Tae Heung ; Park, Yong Sung ; Kim, Jin Hee ; Park, Eun Suk ; Shin, Byung Cheol ; Kim, Tae Woo. / Chemotherapy enhances CD8+ T cell-mediated antitumor immunity induced by vaccination with vaccinia virus. In: Molecular Therapy. 2007 ; Vol. 15, No. 8. pp. 1558-1563.
@article{f2a2bb99dc114d42b0ae386437bb3eb6,
title = "Chemotherapy enhances CD8+ T cell-mediated antitumor immunity induced by vaccination with vaccinia virus",
abstract = "The use of immunotherapy or chemotherapy alone is generally ineffective against well-established tumors. To overcome this intrinsic resistance against therapy for tumors, we have attempted to combine immunotherapy with chemotherapy. In this study, we tried to induce a rapid antitumor effect via chemoimmunotherapy using a vaccinia viral vaccine as an immunotherapeutic agent with anticancer agents including epigallocatechin-3-gallate (EGCG) and conventional anticancer drugs. Although a combination of vaccinia-mediated vaccination and chemotherapy led to a strong inhibition of tumor growth, monotherapy alone failed to completely cure tumors. In contrast, intravenous injection of cisplatin (CDDP) or cyclophosphamide (CTX) after vaccinia virus vaccination led to complete regression of the established tumors. Interestingly, anticancer drugs appear to augment the antitumor effect of the vaccinia virus-mediated immunotherapy. This effect is mainly associated with the enhanced tumor-specific CD8+ T cell immune response induced by vaccinia virus, which was demonstrated by antibody depletion. However, anticancer drugs alone failed to induce a significant enhancement of the tumor-specific CD8+ T cell immune response. Taken together, these results suggest that combining vaccinia virus-based immunotherapy with anticancer drugs is particularly effective against established tumors by increasing the tumor antigen-specific CD8+ T cell immune response, which is primed by vaccinia virus-mediated vaccination.",
author = "Song, {Chung Kil} and Han, {Hee Dong} and Noh, {Kyung Hee} and Kang, {Tae Heung} and Park, {Yong Sung} and Kim, {Jin Hee} and Park, {Eun Suk} and Shin, {Byung Cheol} and Kim, {Tae Woo}",
year = "2007",
month = "8",
day = "1",
doi = "10.1038/sj.mt.6300221",
language = "English",
volume = "15",
pages = "1558--1563",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Chemotherapy enhances CD8+ T cell-mediated antitumor immunity induced by vaccination with vaccinia virus

AU - Song, Chung Kil

AU - Han, Hee Dong

AU - Noh, Kyung Hee

AU - Kang, Tae Heung

AU - Park, Yong Sung

AU - Kim, Jin Hee

AU - Park, Eun Suk

AU - Shin, Byung Cheol

AU - Kim, Tae Woo

PY - 2007/8/1

Y1 - 2007/8/1

N2 - The use of immunotherapy or chemotherapy alone is generally ineffective against well-established tumors. To overcome this intrinsic resistance against therapy for tumors, we have attempted to combine immunotherapy with chemotherapy. In this study, we tried to induce a rapid antitumor effect via chemoimmunotherapy using a vaccinia viral vaccine as an immunotherapeutic agent with anticancer agents including epigallocatechin-3-gallate (EGCG) and conventional anticancer drugs. Although a combination of vaccinia-mediated vaccination and chemotherapy led to a strong inhibition of tumor growth, monotherapy alone failed to completely cure tumors. In contrast, intravenous injection of cisplatin (CDDP) or cyclophosphamide (CTX) after vaccinia virus vaccination led to complete regression of the established tumors. Interestingly, anticancer drugs appear to augment the antitumor effect of the vaccinia virus-mediated immunotherapy. This effect is mainly associated with the enhanced tumor-specific CD8+ T cell immune response induced by vaccinia virus, which was demonstrated by antibody depletion. However, anticancer drugs alone failed to induce a significant enhancement of the tumor-specific CD8+ T cell immune response. Taken together, these results suggest that combining vaccinia virus-based immunotherapy with anticancer drugs is particularly effective against established tumors by increasing the tumor antigen-specific CD8+ T cell immune response, which is primed by vaccinia virus-mediated vaccination.

AB - The use of immunotherapy or chemotherapy alone is generally ineffective against well-established tumors. To overcome this intrinsic resistance against therapy for tumors, we have attempted to combine immunotherapy with chemotherapy. In this study, we tried to induce a rapid antitumor effect via chemoimmunotherapy using a vaccinia viral vaccine as an immunotherapeutic agent with anticancer agents including epigallocatechin-3-gallate (EGCG) and conventional anticancer drugs. Although a combination of vaccinia-mediated vaccination and chemotherapy led to a strong inhibition of tumor growth, monotherapy alone failed to completely cure tumors. In contrast, intravenous injection of cisplatin (CDDP) or cyclophosphamide (CTX) after vaccinia virus vaccination led to complete regression of the established tumors. Interestingly, anticancer drugs appear to augment the antitumor effect of the vaccinia virus-mediated immunotherapy. This effect is mainly associated with the enhanced tumor-specific CD8+ T cell immune response induced by vaccinia virus, which was demonstrated by antibody depletion. However, anticancer drugs alone failed to induce a significant enhancement of the tumor-specific CD8+ T cell immune response. Taken together, these results suggest that combining vaccinia virus-based immunotherapy with anticancer drugs is particularly effective against established tumors by increasing the tumor antigen-specific CD8+ T cell immune response, which is primed by vaccinia virus-mediated vaccination.

UR - http://www.scopus.com/inward/record.url?scp=34547113994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547113994&partnerID=8YFLogxK

U2 - 10.1038/sj.mt.6300221

DO - 10.1038/sj.mt.6300221

M3 - Article

VL - 15

SP - 1558

EP - 1563

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 8

ER -